CIK: 0001595855
Total reported value
$759.2M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | HROW | Harrow INC | Stock-Other | 26.60% | -12.10% | — | |
| 2 | ETON | Eton Pharmaceuticals INC | Stock-Other | 8.79% | +2.92% | — | |
| 3 | LQDA | Liquidia CORP | Stock-Other | 8.41% | +0.49% | +5.66% | |
| 4 | RYTM | Rhythm Pharmaceuticals INC | Stock-Other | 6.59% | — | -2.80% | |
| 5 | IMNM | Immunome INC | Stock-Other | 5.27% | — | -9.76% | |
| 6 | SNWV | Sanuwave Health INC | Stock-Other | 5.19% | -1.63% | — | |
| 7 | CDXS | Codexis INC | Stock-Other | 4.41% | — | +1.55% | |
| 8 | TGTX | Tg Therapeutics INC | Stock-Healthcare | 2.73% | +0.24% | — | |
| 9 | OCUL | Ocular Therapeutix INC | Stock-Other | 2.64% | -1.88% | — | |
| 10 | CGON | Cg Oncology INC | Stock-Other | 2.33% | -1.40% | +54.14% | |
| 11 | STOK | Stoke Therapeutics INC | Stock-Other | 2.27% | +0.09% | +21.33% | |
| 12 | APGE | Apogee Therapeutics INC | Stock-Other | 2.04% | +0.45% | — | |
| 13 | ALKS | Alkermes plc | Stock-Healthcare | 1.91% | -1.81% | EXIT | |
| 14 | IRON | Disc Medicine INC | Stock-Other | 1.81% | +1.45% | +3.95% | |
| 15 | SRPT | Sarepta Therapeutics INC | Stock-Healthcare | 1.59% | — | +17.00% | |
| 16 | LRMR | Larimar Therapeutics INC | Stock-Other | 1.49% | — | -9.47% | |
| 17 | XOMA | Xoma Royalty Corporation | Stock-Other | 1.39% | +0.21% | — | |
| 18 | RZLT | Rezolute INC | Stock-Other | 1.20% | +0.57% | — | |
| 19 | ARVN | Arvinas INC | Stock-Other | 1.19% | — | -41.20% | |
| 20 | EWTX | Edgewise Therapeutics INC | Stock-Other | 1.15% | +0.43% | +2.04% | |
| 21 | ANNX | Annexon INC | Stock-Other | 1.12% | — | — | |
| 22 | GOSS | Gossamer Bio INC | Stock-Other | 1.01% | -1.11% | EXIT | |
| 23 | PTGX | Protagonist Therapeutics INC | Stock-Other | 0.99% | +0.18% | — | |
| 24 | DERM | Journey Medical CORP | Stock-Other | 0.98% | -0.40% | +922.17% | |
| 25 | ✓ | Stock-Other | 0.84% | +2.70% | — | ||
| 26 | PLX | Protalix Biotherapeutics INC | Stock-Other | 0.81% | -0.49% | — | |
| 27 | TMCI | Treace Medical Concepts INC | Stock-Other | 0.67% | — | — | |
| 28 | RVMD | Revolution Medicines INC | Stock-Healthcare | 0.66% | +0.23% | -4.76% | |
| 29 | KPTI 3 10-15-25 | Karyopharm Therapeutics | Stock-Other | 0.65% | — | — | |
| 30 | MBX | Mbx Biosciences INC | Stock-Other | 0.63% | — | +5.72% | |
| 31 | TRVI | Trevi Therapeutics INC | Stock-Other | 0.50% | — | — | |
| 32 | ✓ | Adc Therapeutics SA | Stock-Other | 0.39% | — | — | |
| 33 | ALMS | Alumis INC | Stock-Other | 0.38% | +0.91% | -14.19% | |
| 34 | CABA | Cabaletta Bio INC | Stock-Other | 0.27% | +0.23% | — | |
| 35 | IRD | Opus Genetics INC | Stock-Other | 0.26% | — | -9.84% | |
| 36 | ZYME | Zymeworks INC | Stock-Other | 0.24% | -0.38% | EXIT | |
| 37 | SYRE | Spyre Therapeutics INC | Stock-Other | 0.15% | — | — | |
| 38 | RIGL | Rigel Pharmaceuticals INC | Stock-Other | 0.15% | -0.15% | — | |
| 39 | ACOG | Alpha Cognition INC | Stock-Other | 0.11% | +0.07% | — | |
| 40 | ZNTL | Zentalis Pharmaceuticals INC | Stock-Other | 0.07% | +0.19% | -83.55% | |
| 41 | PEPG | Pepgen INC | Stock-Other | 0.05% | — | -68.75% | |
| 42 | IBIO | Ibio INC | Stock-Other | 0.04% | — | — | |
| 43 | ADGM | Adagio Medical Holdings INC | Stock-Other | 0.03% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | HROW | Harrow INC | +3.2% | — | Trim |
| 2 | STOK | Stoke Therapeutics INC | +1.8% | +21.33% | Add |
| 3 | CGON | Cg Oncology INC | +1.4% | +54.14% | Add |
| 4 | LQDA | Liquidia CORP | +1% | +5.66% | Add |
| 5 | RZLT | Rezolute INC | +0.9% | — | Add |
| 6 | DERM | Journey Medical CORP | +0.9% | +922.17% | Add |
| 7 | IRON | Disc Medicine INC | +0.9% | +3.95% | Add |
| 8 | RYTM | Rhythm Pharmaceuticals INC | +0.8% | -2.80% | Trim |
| 9 | LRMR | Larimar Therapeutics INC | +0.6% | -9.47% | Add |
| 10 | ETON | Eton Pharmaceuticals INC | +0.6% | — | Add |
| 11 | XOMA | Xoma Royalty Corporation | +0.3% | — | Add |
| 12 | MBX | Mbx Biosciences INC | +0.2% | +5.72% | Add |
| 13 | OCUL | Ocular Therapeutix INC | 0% | — | Unchanged |
| 14 | GOSS | Gossamer Bio INC | 0% | -23.13% | Trim |
| 15 | IMNM | Immunome INC | -0.1% | -9.76% | Trim |
| 16 | PTGX | Protagonist Therapeutics INC | -0.1% | — | Unchanged |
| 17 | IBIO | Ibio INC | -0.3% | — | Unchanged |
| 18 | TRVI | Trevi Therapeutics INC | -0.6% | — | Trim |
| 19 | ZNTL | Zentalis Pharmaceuticals INC | -0.6% | -83.55% | Trim |
| 20 | CDXS | Codexis INC | -1.3% | +1.55% | Add |
| 21 | ARVN | Arvinas INC | -1.9% | -41.20% | Trim |
| 22 | TGTX | Tg Therapeutics INC | -2% | — | Unchanged |
| 23 | SNWV | Sanuwave Health INC | -2.5% | — | Add |
| 24 | APGE | Apogee Therapeutics INC | — | NEW | New buy |
| 25 | ALKS | Alkermes plc | — | NEW | New buy |
| 26 | SRPT | Sarepta Therapeutics INC | — | NEW | New buy |
| 27 | ANNX | Annexon INC | — | NEW | New buy |
| 28 | TARA | Protara Therapeutic INC | — | EXIT | Sold out |
| 29 | DNA | Ginkgo Bioworks Holdings INC | — | EXIT | Sold out |
| 30 | GOSS 5 06-01-27 | Gossamer Bio INC | — | EXIT | Sold out |
| 31 | ✓ | — | NEW | New buy | |
| 32 | ANIK | Anika Therapeutics INC | — | EXIT | Sold out |
| 33 | PLX | Protalix Biotherapeutics INC | — | NEW | New buy |
| 34 | PVLA | Palvella Therapeutics INC | — | EXIT | Sold out |
| 35 | TMCI | Treace Medical Concepts INC | — | NEW | New buy |
| 36 | RVMD | Revolution Medicines INC | — | NEW | New buy |
| 37 | ANAB | Anaptysbio INC | — | EXIT | Sold out |
| 38 | ✓ | Acelyrin INC | — | EXIT | Sold out |
| 39 | RCEL | Avita Medical INC | — | EXIT | Sold out |
| 40 | EPIEUR | Essa Pharma INC | — | EXIT | Sold out |
| 41 | ✓ | Adc Therapeutics SA | — | NEW | New buy |
| 42 | CRGX | Cargo Therapeutics INC | — | EXIT | Sold out |
| 43 | ALMS | Alumis INC | — | NEW | New buy |
| 44 | ✓ | Biodesix INC | — | EXIT | Sold out |
| 45 | CABA | Cabaletta Bio INC | — | NEW | New buy |
| 46 | OPTNUSD | Optinose INC | — | EXIT | Sold out |
| 47 | KNSA | Kiniksa Pharmaceuticals International, plc | — | EXIT | Sold out |
| 48 | NRIX | Nurix Therapeutics INC | — | EXIT | Sold out |
| 49 | SYRE | Spyre Therapeutics INC | — | NEW | New buy |
| 50 | RIGL | Rigel Pharmaceuticals INC | — | NEW | New buy |